carbamazepine has been researched along with propranolol in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (12.38) | 18.7374 |
1990's | 12 (11.43) | 18.2507 |
2000's | 27 (25.71) | 29.6817 |
2010's | 47 (44.76) | 24.3611 |
2020's | 6 (5.71) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Blake, JF; Curatolo, WJ; Lombardo, F | 1 |
Strassburg, CP; Tukey, RH | 1 |
Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Hwang, KK; Mandagere, AK; Thompson, TN | 1 |
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Giralt, E; Malakoutikhah, M; Teixidó, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Botta, M; Dreassi, E; Falchi, F; Maga, G; Santucci, A; Schenone, S; Zizzari, AT | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Giralt, E; Malakoutikhah, M; Prades, R; Teixidó, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bříza, T; D'Acunto, CW; Gbelcová, H; Havlík, M; Kaplánek, R; Kejík, Z; Král, V; Ruml, T; Vasina, L | 1 |
Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Courtioux, B; Fairlamb, A; Hutter, S; Laget, M; Moreau, A; Mothes, E; Paloque, L; Pedron, J; Pratviel, G; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vendier, L; Verhaeghe, P; Wyllie, S | 1 |
Bae, MA; Choi, J; Choi, JH; Kim, MJ; Kim, YC; Lee, D; Lee, KR; Lee, S; Park, CJ; Seo, J; Shin, DS; Song, YK | 1 |
Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
von Wichert, P | 1 |
Rane, A; Wilson, JT | 1 |
Mandoki, MW; Matthews-Ferrari, K; Sumner, GS | 1 |
Christison, GW; Kirch, DG; Wyatt, RJ | 1 |
Mattes, JA | 4 |
Brotman, AW; Ford, HE; Renshaw, PF | 1 |
Barnes, R; Risse, SC | 1 |
Lerer, B | 1 |
Baldessarini, RJ; Donaldson, SR; Gelenberg, AJ | 1 |
Sheard, MH | 1 |
Cavalieri, RR; Pitt-Rivers, R | 1 |
Mattes, JA; Mays, D; Rosenberg, J | 1 |
Müller, FO; Steyn, JM | 1 |
Levenson, J; Pandurangi, A; Silverman, J; Vieweg, V | 1 |
Mayer, T; Specht, U | 1 |
Vanelle, JM | 1 |
Cowley, DS; Ries, RK; Roy-Byrne, PP; Sullivan, MD | 1 |
Grahn, A; Hermansson, J | 1 |
Campos, J; Carvalho, MJ; Costa, O; Cunha, DL; Freitas, AF; Freitas, J; Garcia, JM; Gomes, MC; Puig, J | 1 |
De Sarro, A; De Sarro, G; Di Paola, ED; Ferreri, G; Fischer, W | 1 |
Ferrari, B; Fraysse, B; Garric, J; Lo Giudice, R; Mons, R; Paxéus, N; Pollio, A; Vollat, B | 1 |
Drillia, P; Fountoulakis, M; Lyberatos, G; Stamatelatou, K | 1 |
Dokianakis, SN; Kornaros, ME; Lyberatos, G | 1 |
Drillia, P; Lyberatos, G; Stamatelatou, K | 1 |
Biebow, M; Boller, M; Pronk, W | 1 |
Landess, JS; Martin, PR; Raj, V | 1 |
Adriaensen, J; Augustijns, P; Brewster, ME; Mackie, C; Melis, A; Mensch, J; Noppe, M | 1 |
Kawasaki, A; Purvin, VA; Williams, PE | 1 |
Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX | 1 |
Cooks, RG; Ifa, DR; Kistler, T; Manicke, NE; Ouyang, Z | 1 |
Banks, E; Grover, D; Jiang, JQ; Zhang, ZL; Zhou, JL | 1 |
Barceló, D; Caminal, G; Marco-Urrea, E; Petrović, M; Radjenović, J; Vicent, T | 1 |
Maskaoui, K; Zhou, JL | 1 |
Barreiro, JC; Cass, QB; Madureira, TV; Rocha, E; Rocha, MJ; Tiritan, ME | 1 |
Koester, LS; Kratz, JM; Simões, CM; Teixeira, MR | 1 |
Cruzeiro, C; Madureira, TV; Rocha, E; Rocha, MJ | 1 |
Kühne, S; Steinert, M; Untucht, C; Wätzig, H | 1 |
Alonso, E; Aparicio, I; Camacho-Muñoz, MA; Martín, J; Santos, JL | 1 |
Cruzeiro, C; Madureira, TV; Monteiro, RA; Rocha, E; Rocha, MJ; Rodrigues, I | 1 |
Jasper, JT; Sedlak, DL | 1 |
Hui-Ping Khor, A; Lim, KS; Lo, YL; Ng, CC; Yeap, LL | 1 |
Cho, K; Choi, KJ; Hong, SW; Jeong, B; Lee, C; Lee, J; Lee, Y; Maeng, SK | 1 |
Barata, C; Campos, B; Rivetti, C | 1 |
Batley, GE; Hutchinson, TH; Kumar, A; Nidumolu, B | 1 |
Ali, R; Bodmeier, R; Dashevsky, A | 1 |
Baranowska, I; Buszewski, B; Gadzała-Kopciuch, R; Kochańska, K; Konieczka, P; Kościelniak, P; Magiera, S; Namieśnik, J; Polkowska-Motrenko, H; Rutkowska, M; Samczyński, Z; Woźniakiewicz, A | 1 |
Fabbri, E; Franzellitti, S; Pretolani, F; Striano, T | 1 |
Baron, MG; Hetheridge, MJ; Jackson, SK; Jha, AN; Mintram, KS; Moody, AJ; Owen, SF; Purcell, WM | 1 |
Simpson, AJ; Simpson, MJ; Wagner, ND | 1 |
Abe, K; Hashimura, M; Iha, HA; Iwai, C; Kato, M; Kawaji, S; Kawakita, K; Kunisawa, N; Ogawa, M; Ohno, Y; Shimizu, S | 1 |
García-Espinoza, JD; Mijaylova Nacheva, P | 1 |
Ali, R; Chaerunisaa, AY; Dashevskiy, A | 1 |
Hollender, J; Jeon, J | 1 |
Balbi, T; Canesi, L; Fabbri, E; Fabbri, R; Franzellitti, S; Montagna, M; Valbonesi, P | 1 |
Chen, S; Hu, Y; Huang, W; Luo, Y; Wang, P; Wen, W; Wu, J; Xiang, L; Xu, S; Yang, Y | 1 |
Ali, R; Bodmeier, R; Chaerunisaa, AY; Körber, M | 1 |
Chang, H; Chen, C; Du, H; Guan, C; Li, C; Qiu, L; Wang, S; Wang, T; Wu, Y; Zhang, L; Zhang, S; Zhou, H | 1 |
Bodmeier, R; Chaerunisaa, AY; Muhaimin, M | 1 |
12 review(s) available for carbamazepine and propranolol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dementia; Humans; Lithium; Lithium Carbonate; Propranolol; Psychotropic Drugs | 1986 |
Psychopharmacology of temper outbursts. A review.
Topics: Adolescent; Aggression; Anger; Animals; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lithium; Male; Mental Disorders; Propranolol; Rage; Thyroid Gland | 1986 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adult; Aged; Aggression; Anger; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; Carbamazepine; Child; Child Abuse; Child, Preschool; Epilepsy; Female; gamma-Aminobutyric Acid; Humans; Lithium; Male; Middle Aged; Mood Disorders; Prisoners; Propranolol; Psychotic Disorders | 1984 |
The effects of drugs on the distribution and metabolism of thyroid hormones.
Topics: Animals; Antithyroid Agents; Carbamazepine; Carcinogens; Female; Heparin; Hormones; Humans; Male; Phenobarbital; Phenytoin; Pregnancy; Propranolol; Salicylates; Thyroid Hormones; Thyroxine-Binding Proteins | 1981 |
The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Carbamazepine; Cognition Disorders; Demeclocycline; Drinking Behavior; Electroconvulsive Therapy; Humans; Hyponatremia; Lithium; Mood Disorders; Naloxone; Phenytoin; Polyuria; Propranolol; Psychiatry; Psychotherapy; Schizophrenia; Sodium Chloride; Syndrome; Water Intoxication; Workforce | 1994 |
[Resistant schizophrenia: what chemotherapy?].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Drug Therapy, Combination; Humans; Lithium; Propranolol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1993 |
Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
Topics: Anti-Anxiety Agents; Benzodiazepines; Carbamazepine; Clonidine; Combined Modality Therapy; Humans; Panic Disorder; Propranolol; Psychotherapy; Psychotropic Drugs; Recurrence; Substance Withdrawal Syndrome | 1993 |
[Malignant vasovagal syncope: a case of prolonged asystole induced by the "tilt" test and aggravated by therapy with a beta blocker (a clinical case and diagnostic, physiopathologic and therapeutic review)].
Topics: Adult; Carbamazepine; Electrocardiography; Heart Arrest; Heart Function Tests; Humans; Male; Posture; Propranolol; Scopolamine; Syncope | 1993 |
6 trial(s) available for carbamazepine and propranolol
Article | Year |
---|---|
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
Comparative effectiveness of carbamazepine and propranolol for rage outbursts.
Topics: Adolescent; Adult; Aggression; Antisocial Personality Disorder; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Female; Humans; Male; Mental Disorders; Propranolol; Rage | 1990 |
Carbamazepine vs. propranolol for rage outbursts.
Topics: Adult; Anger; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Propranolol; Rage; Random Allocation | 1988 |
Psychopharmacology of temper outbursts. A review.
Topics: Adolescent; Aggression; Anger; Animals; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lithium; Male; Mental Disorders; Propranolol; Rage; Thyroid Gland | 1986 |
Carbamazepine versus propranolol in patients with uncontrolled rage outbursts: a random assignment study.
Topics: Adolescent; Anger; Carbamazepine; Child Behavior Disorders; Humans; Propranolol; Rage; Random Allocation | 1984 |
Propranolol in startle induced epileptic seizures.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Clobazam; Epilepsy, Complex Partial; Epilepsy, Generalized; Humans; Propranolol; Reflex, Startle | 1995 |
89 other study(ies) available for carbamazepine and propranolol
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Computation of brain-blood partitioning of organic solutes via free energy calculations.
Topics: Animals; Blood-Brain Barrier; Brain; Cattle; Cells, Cultured; Endothelium, Vascular; Membrane Lipids; Microcirculation; Molecular Conformation; Molecular Structure; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Software; Solubility; Thermodynamics | 1996 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Dogs; Guinea Pigs; Humans; In Vitro Techniques; Inactivation, Metabolic; Liver; Microsomes, Liver; Models, Biological; Permeability; Pharmacokinetics; Rats; Species Specificity | 2002 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.
Topics: Biological Transport; Blood-Brain Barrier; Cell Survival; Drug Carriers; Humans; Levodopa; Membranes, Artificial; Peptide Library; Peptides; Permeability; Phenylalanine; Solubility | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
Topics: Humans; Lipids; Membranes, Artificial; Permeability; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles.
Topics: Aminolevulinic Acid; Animals; Animals, Newborn; Astrocytes; Biological Transport; Blood Vessels; Blood-Brain Barrier; Brain; Cattle; Cell Membrane Permeability; Cells, Cultured; Chromatography, High Pressure Liquid; Coculture Techniques; Drug Carriers; Endothelial Cells; gamma-Aminobutyric Acid; Mass Spectrometry; Molecular Structure; Nipecotic Acids; Oligopeptides; Phenylalanine; Rats | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Metallomics for Alzheimer's disease treatment: Use of new generation of chelators combining metal-cation binding and transport properties.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cations; Cell Proliferation; Cell Survival; Chelating Agents; Chelation Therapy; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Metals; Molecular Structure; Protein Aggregates; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
Topics: Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Electrochemical Techniques; Hep G2 Cells; Humans; Kinetoplastida; Leishmania infantum; Molecular Structure; Nitroquinolines; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma brucei brucei | 2018 |
Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives.
Topics: Animals; Caco-2 Cells; Cell Membrane Permeability; Cyclization; Cyclophilin A; Cyclosporine; Cyclosporins; Drug Design; Humans; Hydrogen Bonding; Male; Mice, Inbred ICR; Molecular Conformation; Protein Binding | 2021 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
[Drug side-effects in the lung].
Topics: Antineoplastic Agents; Asthma; Carbamazepine; Cromolyn Sodium; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension, Pulmonary; Nitrofurantoin; Propranolol; Pulmonary Fibrosis; Respiratory Distress Syndrome; Respiratory Insufficiency; Respiratory Tract Diseases; Sulfonamides | 1978 |
Clinical pharmacokinetics in infants and children.
Topics: Aging; Body Water; Carbamazepine; Child; Child, Preschool; Clindamycin; Dextropropoxyphene; Diazoxide; Dicloxacillin; Digoxin; Ethosuximide; Humans; Infant; Infant, Newborn; Kidney; Kinetics; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Propranolol; Sulfonamides; Tetracycline; Theophylline | 1976 |
Practice parameters for the assessment and treatment of conduct disorders. American Academy of Child and Adolescent Psychiatry.
Topics: Adolescent; Ambulatory Care; Antidepressive Agents; Carbamazepine; Child; Child Behavior Disorders; Female; Hospitalization; Humans; Male; Propranolol; Psychotherapy | 1992 |
Evaluation and treatment of rage in children and adolescents.
Topics: Adolescent; Adolescent Behavior; Brain; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Electroencephalography; Female; Humans; Lithium Carbonate; Male; Propranolol; Rage; Tomography, X-Ray Computed; Violence; Wechsler Scales | 1992 |
Possible synergistic anticonvulsant effect of propranolol and carbamazepine.
Topics: Adult; Carbamazepine; Drug Synergism; Epilepsy, Temporal Lobe; Female; Humans; Neurocognitive Disorders; Propranolol | 1990 |
Metoprolol for intermittent explosive disorder.
Topics: Adult; Aggression; Anger; Carbamazepine; Humans; Male; Metoprolol; Neurocognitive Disorders; Propranolol; Rage; Violence | 1985 |
The pharmacologic treatment of schizophrenia: a progress report.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate; Prognosis; Propranolol; Schizophrenia; Schizophrenic Psychology | 1983 |
Comparative effects of two commercially available blood collection tubes on plasma concentrations of drugs.
Topics: Acebutolol; Blood Specimen Collection; Carbamazepine; Diazepam; Digoxin; Ethosuximide; Humans; Nordazepam; Penbutolol; Pharmaceutical Preparations; Propranolol; Quinidine; Salicylates; Time Factors; Valproic Acid; Warfarin | 1980 |
Determination of drugs by direct injection of plasma into a biocompatible extraction column based on a protein-entrapped hydrophobic phase.
Topics: Biocompatible Materials; Blood Proteins; Carbamazepine; Chromatography, High Pressure Liquid; Humans; Ibuprofen; Naproxen; Pharmaceutical Preparations; Phenytoin; Propranolol; Reproducibility of Results | 1994 |
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Adrenergic beta-Antagonists; Animals; Anticonvulsants; Atenolol; Body Temperature; Carbamazepine; Epilepsy, Reflex; Female; Lamotrigine; Male; Metoprolol; Mice; Mice, Inbred DBA; Motor Activity; Phenobarbital; Propanolamines; Propranolol; Stereoisomerism; Triazines; Valproic Acid | 2002 |
Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
Topics: Animals; Carbamazepine; Clofibric Acid; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Environmental Monitoring; France; Germany; Humans; Ofloxacin; Pharmaceutical Preparations; Propranolol; Risk Assessment; Sulfamethoxazole; Toxicity Tests; Water Pollutants, Chemical | 2004 |
Toxic effect of pharmaceuticals on methanogenesis.
Topics: Bacteria, Anaerobic; Biomass; Carbamazepine; Clofibric Acid; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Methane; Methanomicrobiales; Ofloxacin; Pharmaceutical Preparations; Propranolol; Sewage; Sulfamethoxazole; Time Factors; Toxicity Tests; Waste Disposal, Fluid | 2004 |
On the effect of pharmaceuticals on bacterial nitrite oxidation.
Topics: Bacteria, Anaerobic; Biodegradation, Environmental; Bioreactors; Carbamazepine; Cities; Clofibrate; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Kinetics; Nitrites; Nitrogen; Ofloxacin; Oxidation-Reduction; Pharmaceutical Preparations; Propranolol; Sewage; Sulfamethoxazole; Triclosan; Waste Disposal, Fluid; Water Purification | 2004 |
Fate and mobility of pharmaceuticals in solid matrices.
Topics: Adsorption; Aluminum Silicates; Bacteria, Aerobic; Bacteria, Anaerobic; Carbamazepine; Carbon; Clay; Clofibric Acid; Diclofenac; Models, Theoretical; Ofloxacin; Pharmaceutical Preparations; Propranolol; Sewage; Soil; Sulfamethoxazole; Water Movements; Water Pollutants, Chemical | 2005 |
Electrodialysis for recovering salts from a urine solution containing micropollutants.
Topics: Carbamazepine; Dialysis; Diclofenac; Electrochemistry; Ibuprofen; Propranolol; Salts; Water Pollutants, Chemical | 2006 |
Oxcarbazepine use in essential tremor.
Topics: Adult; Carbamazepine; Essential Tremor; Female; Humans; Oxcarbazepine; Propranolol | 2006 |
Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.
Topics: Ampicillin; Atenolol; Caffeine; Carbamazepine; Chromatography, High Pressure Liquid; Griseofulvin; Permeability; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
Superior oblique myokymia: efficacy of medical treatment.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Diplopia; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Optical Illusions; Phenytoin; Propranolol; Retrospective Studies; Treatment Outcome; Trochlear Nerve Diseases; Valproic Acid | 2007 |
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles | 2008 |
High-throughput quantitative analysis by desorption electrospray ionization mass spectrometry.
Topics: Animals; Automation; Brain Chemistry; Carbamazepine; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Swine | 2009 |
Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water.
Topics: Carbamazepine; Diclofenac; Indomethacin; Pharmaceutical Preparations; Propranolol; Rivers; Sulfamethoxazole; United Kingdom; Water Pollutants, Chemical | 2009 |
Oxidation of atenolol, propranolol, carbamazepine and clofibric acid by a biological Fenton-like system mediated by the white-rot fungus Trametes versicolor.
Topics: Atenolol; Benzoquinones; Biodegradation, Environmental; Carbamazepine; Clofibric Acid; Hydrogen Peroxide; Iron; Oxalates; Oxidation-Reduction; Pharmaceutical Preparations; Propranolol; Trametes; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Colloids as a sink for certain pharmaceuticals in the aquatic environment.
Topics: Carbamazepine; Colloids; Diclofenac; Environmental Restoration and Remediation; Fresh Water; Indomethacin; Meclofenamic Acid; Pharmaceutical Preparations; Phenethylamines; Propranolol; Sewage; Sulfamethoxazole; Tamoxifen; Thioridazine; Water Pollutants, Chemical | 2010 |
Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal).
Topics: Carbamazepine; Chromatography, Liquid; Diazepam; Environmental Monitoring; Fenofibrate; Pharmaceutical Preparations; Portugal; Propranolol; Risk Assessment; Rivers; Solid Phase Extraction; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical | 2010 |
An HPLC-UV method for the measurement of permeability of marker drugs in the Caco-2 cell assay.
Topics: Acyclovir; Caco-2 Cells; Carbamazepine; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Intestinal Mucosa; Pharmaceutical Preparations; Propranolol; Ultraviolet Rays; Verapamil; Vinblastine | 2011 |
The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal)--experimental assessment using a zebrafish embryo test.
Topics: Animals; Anti-Infective Agents; Anticonvulsants; Antihypertensive Agents; Carbamazepine; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Female; Fenofibrate; Heart Rate; Hypolipidemic Agents; Male; Pharmaceutical Preparations; Portugal; Propranolol; Random Allocation; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Zebrafish | 2011 |
Fast investigations from biological matrices using CE--test of a blood-brain barrier model.
Topics: Acetaminophen; Adsorption; Animals; Blood-Brain Barrier; Caffeine; Carbamazepine; Cell Culture Techniques; Cell Line; Chromatography, Micellar Electrokinetic Capillary; Cimetidine; Humans; Indomethacin; Limit of Detection; Models, Biological; Propranolol; Rats; Reproducibility of Results; Tissue Distribution | 2012 |
Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. Risk assessment of sludge application onto soils.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Carbamazepine; Clofibric Acid; Environmental Pollutants; Environmental Pollution; Estradiol; Gemfibrozil; Propranolol; Risk Assessment; Sewage; Soil; Spain; Time Factors | 2012 |
The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal): evaluation of impacts on fish liver, by histopathology, stereology, vitellogenin and CYP1A immunohistochemistry, after sub-acute exposures of the zebrafish model.
Topics: Animals; Carbamazepine; Cytochrome P-450 CYP1A1; Female; Fenofibrate; Fish Proteins; Liver; Male; Portugal; Propranolol; Rivers; Sulfamethoxazole; Trimethoprim; Vitellogenins; Water Pollutants, Chemical; Zebrafish | 2012 |
Phototransformation of wastewater-derived trace organic contaminants in open-water unit process treatment wetlands.
Topics: Atenolol; Carbamazepine; Carbonates; Cimetidine; Dimethylnitrosamine; Diuron; Estradiol; Hydroxyl Radical; Models, Chemical; Photolysis; Propranolol; Sulfamethoxazole; Sunlight; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Wetlands | 2013 |
Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis.
Topics: Adult; Anticonvulsants; Antithyroid Agents; Carbamazepine; Carbimazole; Dose-Response Relationship, Drug; Drug Monitoring; Epilepsy; Female; Genetic Variation; Genotype; Humans; Hyperthyroidism; Malaysia; Medication Adherence; Multidrug Resistance-Associated Protein 2; Polymorphism, Genetic; Propranolol; Thyrotoxicosis | 2014 |
Substrate-immobilized electrospun TiO2 nanofibers for photocatalytic degradation of pharmaceuticals: The effects of pH and dissolved organic matter characteristics.
Topics: Carbamazepine; Catalysis; Cimetidine; Hydrogen-Ion Concentration; Nanofibers; Organic Chemicals; Photolysis; Propranolol; Titanium; Ultraviolet Rays; Water Pollutants, Chemical; Water Purification | 2015 |
Low environmental levels of neuro-active pharmaceuticals alter phototactic behaviour and reproduction in Daphnia magna.
Topics: Animals; Behavior, Animal; Carbamazepine; Chromatography, High Pressure Liquid; Daphnia; Fluoxetine; Light; Propranolol; Reproduction; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Toxicity Tests; Water Pollutants, Chemical | 2016 |
Derivation of water quality guidelines for priority pharmaceuticals.
Topics: Animals; Aquatic Organisms; Carbamazepine; Diclofenac; Fluoxetine; Fresh Water; Guidelines as Topic; Pharmaceutical Preparations; Propranolol; Toxicity Tests, Chronic; Water Pollutants, Chemical; Water Quality | 2016 |
Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
Topics: Caffeine; Carbamazepine; Chemistry, Pharmaceutical; Drug Compounding; Drug Liberation; Excipients; Hypromellose Derivatives; Permeability; Polymers; Polyvinyls; Propranolol; Solubility; Tablets | 2017 |
Development of potential candidate reference materials for drugs in bottom sediment, cod and herring tissues.
Topics: Acenocoumarol; Animals; Carbamazepine; Chromatography, Liquid; Environmental Monitoring; Fishes; Metoprolol; Naproxen; Propranolol; Reference Standards; Reproducibility of Results; Seafood; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2017 |
Investigating appearance and regulation of the MXR phenotype in early embryo stages of the Mediterranean mussel (Mytilus galloprovincialis).
Topics: Animals; Aquaculture; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Carbamazepine; Fertilization in Vitro; Fluorescent Dyes; Gene Expression Regulation, Developmental; Italy; Larva; Mediterranean Sea; Membrane Transport Modulators; Morphogenesis; Multidrug Resistance-Associated Proteins; Mytilus; Propranolol; Rhodamine 123; RNA, Messenger; Teratogens; Zygote | 2017 |
Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.
Topics: Animals; Atenolol; Biotransformation; Carbamazepine; Diazepam; Diclofenac; Drug Evaluation, Preclinical; Female; Kinetics; Liver; Metoprolol; Models, Animal; Oncorhynchus mykiss; Phenylbutazone; Propranolol; Tandem Mass Spectrometry; Water Pollutants, Chemical; Xenobiotics | 2017 |
Sublethal metabolic responses to contaminant mixture toxicity in Daphnia magna.
Topics: Alkanesulfonic Acids; Animals; Carbamazepine; Daphnia; Dose-Response Relationship, Drug; Fluorocarbons; Metabolome; Metabolomics; Propranolol; Wastewater; Water Pollutants, Chemical | 2018 |
Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents.
Topics: Animals; Anticonvulsants; Antiparkinson Agents; Benzeneacetamides; Calcium Channel Blockers; Carbamazepine; Diazepam; Disease Models, Animal; Essential Tremor; Ethosuximide; Male; Mice, Inbred Strains; Nicotine; Phenobarbital; Propranolol; Pyridines; Valproic Acid | 2018 |
Effect of electrolytes on the simultaneous electrochemical oxidation of sulfamethoxazole, propranolol and carbamazepine: behaviors, by-products and acute toxicity.
Topics: Boron; Carbamazepine; Diamond; Electrodes; Electrolytes; Gas Chromatography-Mass Spectrometry; Oxidation-Reduction; Propranolol; Sulfamethoxazole; Titanium; Toxicity Tests, Acute; Water Pollutants, Chemical | 2019 |
Release Adjustment of Two Drugs with Different Solubility Combined in a Matrix Tablet.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Carbamazepine; Cellulose; Hypromellose Derivatives; Propranolol; Solubility; Tablets | 2019 |
In vitro biotransformation of pharmaceuticals and pesticides by trout liver S9 in the presence and absence of carbamazepine.
Topics: Animals; Biotransformation; Carbamazepine; Chromatography, Liquid; In Vitro Techniques; Liver; Pesticides; Pharmaceutical Preparations; Propranolol; Subcellular Fractions; Tandem Mass Spectrometry; Trout; Water Pollutants, Chemical | 2019 |
Phenotypical and molecular changes induced by carbamazepine and propranolol on larval stages of Mytilus galloprovincialis.
Topics: Animals; Carbamazepine; Embryonic Development; Larva; Mytilus; Propranolol; Water Pollutants, Chemical | 2019 |
Vanillin enhances the passive transport rate and absorption of drugs with moderate oral bioavailability in vitro and in vivo by affecting the membrane structure.
Topics: Acyclovir; Administration, Oral; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Antiviral Agents; Area Under Curve; Benzaldehydes; Biological Availability; Biological Transport; Caco-2 Cells; Carbamazepine; Diuretics; Humans; Hydrochlorothiazide; In Vitro Techniques; Intestinal Absorption; Male; Plant Extracts; Propranolol; Rats; Rats, Sprague-Dawley | 2020 |
Quantification of porogen effect on the drug release from single- and multi-layered ethylcellulose coated pellets containing single or combined drugs.
Topics: Caffeine; Carbamazepine; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Models, Theoretical; Porosity; Propranolol; Solubility; Water | 2020 |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.
Topics: Animals; Antipyrine; Atenolol; Carbamazepine; Cell Membrane; Digoxin; Diltiazem; Diphenhydramine; Drug Elimination Routes; Gabapentin; Lamotrigine; Liver; Memantine; Membrane Transport Proteins; Microdialysis; Muscle, Skeletal; Ofloxacin; Pharmaceutical Preparations; Propranolol; Pyrilamine; Quinidine; Rats; Terfenadine | 2021 |
Impact of dispersion time interval and particle size on release profiles of propranolol HCl and carbamazepines from microparticle blends system.
Topics: Carbamazepine; Emulsions; Microspheres; Particle Size; Propranolol | 2022 |